Clinical predictors of GH deficiency in surgically cured acromegalic patients
Open accessThe DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
Objective: Even in patients with cured acromegaly, GH deficiency (GHD) after transsphenoidal adenomectomy (TSA) adversely affects body composition and inflammatory biomarkers of cardiovascular risk. In this study, clinical parameters for predicting GHD after TSA in 123 cured acromegalic patients were investigated. Design and methods: GH levels were measured at 6, 12, 18, 24, 48, and 72 h after TSA and serial insulin tolerance tests were conducted at 6 months, 2 years, and then every 2 years after TSA. Results: GHD was found in 12 patients (9.8%) at 4.1 (range: 0.5–4.1) years after TSA. IGF1 levels were significantly lower at 6 months after TSA in GHD group than intact GH group (175.9 vs 316.8 μg/l, range: 32.0–425.0 and 96.9–547.3 respectively, P=0.008). Adenomas involving both sides of the pituitary gland were significantly more frequent in GHD patients (29.7 vs 83.3%; P=0.002). Furthermore, immediate postoperative 72-h GH levels after TSA were significantly lower (0.17 vs 0.45, range: 0.02–0.93 and 0.02–5.95 respectively, P=0.019) in GHD patients. In multiple logistic regression analysis, bilaterality of tumor involvement (odds ratio (OR)=10.678, P=0.003; 95% CI=2.248–50.728) and immediate postoperative 72-h GH level (OR=0.079, P=0.047; 95% CI=0.006–0.967) showed significant power for predicting GHD. Conclusions: These data suggest that bilateral involvement of a pituitary adenoma and severely decreased immediate postoperative serum GH levels at 72 h after TSA may be independent risks factor for accelerated GHD in acromegalic patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a randomized placebo-controlled study, mean GH doses of 0.58 mg/day resulted in decreased visceral fat mass and improved QOL indices (231).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [231]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Melmed, S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062453 · Cited by 1,160
Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review
Carroll, P. V., Christ the members of Growth Hormon, E. R., Bengtsson, B. Å., Carlsson, L., Christiansen, J. S., Clemmons, D., Hintz, R., Ho, K., Laron, Z., Sizonenko, P., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.2.4594 · Cited by 822
A Consensus on Criteria for Cure of Acromegaly
Giustina, A., Chanson, P., Bronstein, M. D., Klibanski, A., Lamberts, S., Casanueva, F. F., Trainer, P., Ghigo, E., Ho, K., & Melmed, S. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2670 · Cited by 783
Mortality in Acromegaly: A Metaanalysis
Dekkers, O. M., Biermasz, N. R., Pereira, A. M., Romijn, J. A., & Vandenbroucke, J. P. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1191 · Cited by 517
Kreutzer, J., Vance, M. L., Lopes, M. B. S., & Laws, E. R. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4072 · Cited by 341
Freda, P. U., Wardlaw, S. L., & Post, K. D. (1998) · Journal of Neurosurgery · doi:10.3171/jns.1998.89.3.0353 · Cited by 281
Svensson, J., Bengtsson, B.-Å., Rosén, T., Odén, A., & Johannsson, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031601 · Cited by 237
PITUITARY HORMONAL LOSS AND RECOVERY AFTER TRANSSPHENOIDAL ADENOMA REMOVAL
Fatemi, N., Dusick, J. R., Mattozo, C., McArthur, D. L., Cohan, P., Boscardin, J., Wang, C., Swerdloff, R. S., & Kelly, D. F. (2008) · Neurosurgery · doi:10.1227/01.neu.0000325725.77132.90 · Cited by 222
Freda, P. U., Post, K. D., Powell, J. S., & Wardlaw, S. L. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.11.5266 · Cited by 201
Esposito, F., Dusick, J. R., Cohan, P., Moftakhar, P., McArthur, D., Wang, C., Swerdloff, R. S., & Kelly, D. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1204 · Cited by 192
Research works printed but not linked: 4
- Carroll, 1998, Journal of Clinical Endocrinology & Metabolism, 83, 382, 10.1210/jc.83.2.382 · DOI · Paper page
- 2012, Neurosurgery, 71, ons192
- 2009, Neurosurgery, 64, 62
- Lieman, 2001, Journal of Clinical Endocrinology & Metabolism, 86, 3918, 10.1210/jc.86.8.3918 · doi:10.1210/jc.86.8.3918
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Systemic Complications of Acromegaly and the Impact of the Current Treatment Landscape: An Update
Gadelha, M. R., Kasuki, L., Lim, D. S. T., & Fleseriu, M. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00115 · Cited by 363
Kim, J. H., Lee, J. H., Lee, J. H., Hong, A. R., Kim, Y. J., & Kim, Y. H. (2017) · World Neurosurgery · doi:10.1016/j.wneu.2017.09.194 · Cited by 95
Growth hormone deficiency in treated acromegaly
Mazziotti, G., Marzullo, P., Doga, M., Aimaretti, G., & Giustina, A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2014.10.005 · Cited by 33
Growth hormone deficiency in treated acromegaly and active Cushing's syndrome
Formenti, A. M., Maffezzoni, F., Doga, M., Mazziotti, G., & Giustina, A. (2017) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2017.03.002 · Cited by 26
Metadata
- Authors
- Ku, C. R., Hong, J. W., Kim, E. H., Kim, S. H., & Lee, E. J.
- Affiliations
- Inje University (KR)
- Corresponding author
- Kim, Sun Ho
- Lee, Eun Jig
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-09
- Volume
- 171
- Issue
- 3
- Pages
- 379-387
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2105041056
- Semantic Scholar
- 931d491812669e96277d8e18607e016c420d8033
- Cited by
- 24
- References
- 32
- Citations by year
- 2026: 1 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 1 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 2 · 2014: 1
- FWCI
- 2.41
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by-nc-nd
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Funders
- National Research Foundation
- National Research Foundation of Korea (2011-0016060)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Health Sciences › Medicine › Oncology › Neuroendocrine Tumor Research Advances
- Keywords
- growth hormone deficiency, acromegaly, transsphenoidal adenomectomy, pituitary adenoma, insulin-like growth factor I, insulin tolerance test, risk factors
- MeSH terms
- Acromegaly, Adult, Aged, Female, Follow-Up Studies, Humans, Male, Middle Aged, Postoperative Period, Predictive Value of Tests, Biomarkers, Human Growth Hormone, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical predictors of GH deficiency in surgically cured acromegalic patients. https://app.cochat.ai/papers/10.1530/eje-14-0304
- The paper
- Ku, C. R., Hong, J. W., Kim, E. H., Kim, S. H., & Lee, E. J. (2014). Clinical predictors of GH deficiency in surgically cured acromegalic patients. European Journal of Endocrinology. https://doi.org/10.1530/eje-14-0304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.